Skip to main content

Table 1 Patients characteristics

From: Association of lecithin-cholesterol acyltransferase activity and low-density lipoprotein heterogeneity with atherosclerotic cardiovascular disease risk: a longitudinal pilot study

 

n = 335

Male / Female, n (%)

233 (70) / 102 (30)

Age (years)

62 ± 11

BMI (kg/m2)

24.8 ± 3.8

Hypertension, n (%)

224 (67)

Diabetes mellitus, n (%)

92 (28)

 HbA1c (%)

6.1 ± 0.9

Current smoking, n (%)

26 (7.8)

Dyslipidemia, n (%)

269 (80)

eGFR (ml/min/1.73 m2)

69 ± 17

 CKD Stage 3≥, n (%)

89 (27)

Number of risk factors

4.0 ± 1.5

Cardiovascular disease, n (%)

100 (30)

 Coronary artery disease

87 (26)

 Cerebral infarction

12 (3.6)

 Aortic dissection/aortic aneurysm

4 (1.2)

 Peripheral arterial disease

3 (0.9)

Concomitant drug, n (%)

 Anti-platelets

101 (30)

 ACEs/ARBs

191 (57)

 β blockers

77 (23)

 Calcium channel blockers

183(55)

 Lipid-modifying drugs

201(60)

  Statins

179 (53)

  Fibrates

8 (2.4)

  Ezetimibe

15 (4.5)

  1. BMI body mass index, Hb hemoglobin, e-GFR estimated glomerular flow rate, CKD chronic kidney disease, ACEI angiotensin converting enzyme inhibitor, ARB angiotensin receptor blocker